...
首页> 外文期刊>Tissue antigens. >The nature of recombination in HLA-B*4207.
【24h】

The nature of recombination in HLA-B*4207.

机译:HLA-B * 4207中重组的性质。

获取原文
获取原文并翻译 | 示例
           

摘要

The identification of the novel human leukocyte antigen (HLA)-B*4207 allele, which was found in a blood donor of Caucasian origin, is described. The sequence of the new allele differs from HLA-B*4201 in three nucleotide substitutions in exon 2, resulting in three consecutive amino acid (AA) exchanges at position 69, 70, and 71. AA positions 69 and 70 affect the peptide-binding site of the HLA molecule in the formation of pockets A, B, and C. Therefore, it is likely that the peptide-binding motif of HLA-B*4207 differs from the HLA-B*4201 motif. HLA-B*4207 exhibits a high level of structural homology to HLA-B*08 alleles as well as to HLA-B*4201. Rating of the AA variations of these alleles according to the AA distance matrix score gives the lowest overall matching score between the HLA-B*4207 and the HLA-B*0801 alleles, indicating a high functional similarity. To further address this, homology modeling was performed using B8 as the closest structural template. The portion of the molecule that is accessible to the T-cell receptor and antibodies is identical between B*4207 and B*0801. Under consideration of allele frequencies, close inspection of these sequences shows that the new allele is most likely a result of a recombination involving B*0702 and B*0801. Unfortunately, patient consent could not be obtained for retrospective serological typing to definitively determine whether B*4207 reacts in the B8 serological group.
机译:描述了在白种人血统的供血者中发现的新型人类白细胞抗原(HLA)-B * 4207等位基因的鉴定。新等位基因的序列与HLA-B * 4201的不同之处在于外显子2中的三个核苷酸取代,导致位置69、70和71处三个连续的氨基酸(AA)交换。AA位置69和70会影响肽结合因此,HLA-B * 4207的肽结合基序可能与HLA-B * 4201基序不同。 HLA-B * 4207与HLA-B * 08等位基因以及HLA-B * 4201具有高度的结构同源性。根据AA距离矩阵评分对这些等位基因的AA变异进行评分,可得出HLA-B * 4207和HLA-B * 0801等位基因之间的总体匹配评分最低,表明功能相似性很高。为了进一步解决这个问题,使用B8作为最接近的结构模板进行了同源建模。 T细胞受体和抗体可接近的分子部分在B * 4207和B * 0801之间相同。考虑到等位基因频率,对这些序列的仔细检查表明,新的等位基因很可能是涉及B * 0702和B * 0801重组的结果。不幸的是,无法获得患者的同意以进行回顾性血清学分型,以确定B * 4207是否在B8血清学组中起反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号